IL122655A0 - Resolution of 1-azabicyclo[2.2.2]octan-3-amine, 2-(diphenylmethyl)-N-[[2-methoxy-5-(1-methylethyl)phenyl]methyl] - Google Patents

Resolution of 1-azabicyclo[2.2.2]octan-3-amine, 2-(diphenylmethyl)-N-[[2-methoxy-5-(1-methylethyl)phenyl]methyl]

Info

Publication number
IL122655A0
IL122655A0 IL12265596A IL12265596A IL122655A0 IL 122655 A0 IL122655 A0 IL 122655A0 IL 12265596 A IL12265596 A IL 12265596A IL 12265596 A IL12265596 A IL 12265596A IL 122655 A0 IL122655 A0 IL 122655A0
Authority
IL
Israel
Prior art keywords
octan
diphenylmethyl
azabicyclo
methylethyl
methoxy
Prior art date
Application number
IL12265596A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL122655A0 publication Critical patent/IL122655A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
IL12265596A 1995-07-17 1996-07-04 Resolution of 1-azabicyclo[2.2.2]octan-3-amine, 2-(diphenylmethyl)-N-[[2-methoxy-5-(1-methylethyl)phenyl]methyl] IL122655A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US119195P 1995-07-17 1995-07-17
PCT/IB1996/000648 WO1997003984A1 (en) 1995-07-17 1996-07-04 Resolution of 1-azabicyclo[2.2.2]octan-3-amine, 2-(diphenylmethyl)-n-[[2-methoxy-5-(1-methylethyl)phenyl]methyl]

Publications (1)

Publication Number Publication Date
IL122655A0 true IL122655A0 (en) 1998-08-16

Family

ID=21694832

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12265596A IL122655A0 (en) 1995-07-17 1996-07-04 Resolution of 1-azabicyclo[2.2.2]octan-3-amine, 2-(diphenylmethyl)-N-[[2-methoxy-5-(1-methylethyl)phenyl]methyl]

Country Status (26)

Country Link
US (1) US6008357A (pt)
EP (1) EP0840735B1 (pt)
JP (1) JP3043074B2 (pt)
KR (1) KR100276989B1 (pt)
CN (1) CN1068598C (pt)
AR (1) AR002772A1 (pt)
AT (1) ATE250600T1 (pt)
AU (1) AU697553B2 (pt)
CA (1) CA2227194C (pt)
CO (1) CO4480720A1 (pt)
CZ (1) CZ15098A3 (pt)
DE (1) DE69630123T2 (pt)
DK (1) DK0840735T3 (pt)
ES (1) ES2205039T3 (pt)
HK (1) HK1010195A1 (pt)
HU (1) HUP9900238A3 (pt)
IL (1) IL122655A0 (pt)
MY (1) MY115734A (pt)
NO (1) NO980211L (pt)
NZ (1) NZ310539A (pt)
PE (1) PE8798A1 (pt)
PL (1) PL184261B1 (pt)
PT (1) PT840735E (pt)
RU (1) RU2136681C1 (pt)
WO (1) WO1997003984A1 (pt)
ZA (1) ZA966026B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861526B2 (en) 2002-10-16 2005-03-01 Pfizer Inc. Process for the preparation of (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine
JP2007519710A (ja) * 2004-02-02 2007-07-19 ファイザー・プロダクツ・インク １−（２Ｓ，３Ｓ）−２−ベンズヒドリル−Ｎ−（５−ｔｅｒｔ−ブチル−２−メトキシベンジル）キヌクリジン−３−アミンの製造方法
WO2006055321A2 (en) * 2004-11-10 2006-05-26 Boehringer Ingelheim Chemicals, Inc. Process of making fentanyl intermediates
AU2009324679A1 (en) * 2008-12-09 2011-07-28 University Of Florida Research Foundation, Inc. Kinase inhibitor compounds
US20160332962A1 (en) 2015-05-13 2016-11-17 Janssen Pharmaceutica Nv (s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine
CN108341812A (zh) * 2017-01-23 2018-07-31 科贝源(北京)生物医药科技有限公司 一种含奎宁环化合物的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990005525A1 (en) * 1988-11-23 1990-05-31 Pfizer Inc. Quinuclidine derivatives as substance p antagonists
NO168529C (no) * 1989-09-15 1992-03-04 Chiron Lab As Fremgangsmaate for fremstilling av s-(-) og r-(+)-n-(quinuclidinyl-3)-amider.
ATE211743T1 (de) * 1991-05-22 2002-01-15 Pfizer Substituierte 3-aminochinuclidine
DE69208877T2 (de) * 1991-05-31 1996-07-25 Pfizer Chinuclidinderivate
US5604241A (en) * 1992-10-21 1997-02-18 Pfizer Inc. Substituted benzylaminoquinuclidines as substance P antagonists

Also Published As

Publication number Publication date
HUP9900238A2 (hu) 1999-05-28
NO980211L (no) 1998-03-16
PE8798A1 (es) 1998-03-02
CA2227194C (en) 2002-02-12
PL184261B1 (pl) 2002-09-30
NO980211D0 (no) 1998-01-16
JPH10511102A (ja) 1998-10-27
DK0840735T3 (da) 2004-02-09
NZ310539A (en) 1998-11-25
PL324610A1 (en) 1998-06-08
MY115734A (en) 2003-08-30
KR100276989B1 (ko) 2001-01-15
AU6134896A (en) 1997-02-18
CN1190970A (zh) 1998-08-19
DE69630123T2 (de) 2004-04-08
MX9800538A (es) 1998-05-31
RU2136681C1 (ru) 1999-09-10
ZA966026B (en) 1998-01-16
CN1068598C (zh) 2001-07-18
HUP9900238A3 (en) 2001-08-28
CA2227194A1 (en) 1997-02-06
DE69630123D1 (en) 2003-10-30
CO4480720A1 (es) 1997-07-09
EP0840735B1 (en) 2003-09-24
CZ15098A3 (cs) 1999-02-17
WO1997003984A1 (en) 1997-02-06
HK1010195A1 (en) 1999-06-17
JP3043074B2 (ja) 2000-05-22
ES2205039T3 (es) 2004-05-01
EP0840735A1 (en) 1998-05-13
PT840735E (pt) 2004-02-27
US6008357A (en) 1999-12-28
AU697553B2 (en) 1998-10-08
KR19990029058A (ko) 1999-04-15
AR002772A1 (es) 1998-04-29
ATE250600T1 (de) 2003-10-15

Similar Documents

Publication Publication Date Title
FR2687055B1 (fr) Pinceau pour l'application de vernis a ongles, ou de produit similaire.
ITBO930097A0 (it) Apparecchio per l'equilibratura dinamica di un corpo rotante.
ZA968956B (en) Substituted 2,4-imidazolidinedione compounds as pharmaceutical active ingredients
FR2674300B3 (fr) Axe d'articulation, notamment pour un couvercle.
HU9700574D0 (en) Dimethyl-(3-aryl-but-3-enyl)-amine compounds as pharmaceutical active agents
AU1642095A (en) 3,5-disubstituted tetrahydrofuran-2-ones
IL122987A0 (en) Novel 2,3-dioso-1, 2, 3, 4-tetrahydro-quinoxalinyl derivatives
AU699201B2 (en) Highly fluidized concrete composition
FI941776A0 (fi) Menetelmä 1,2,4-tiadiatsolien valmistamiseksi
IL122655A0 (en) Resolution of 1-azabicyclo[2.2.2]octan-3-amine, 2-(diphenylmethyl)-N-[[2-methoxy-5-(1-methylethyl)phenyl]methyl]
AU7480694A (en) 3-(benzofuran-7-yl)-6-haloalkyluracils
AU1925392A (en) A process for the preparation of n-(2,6-dichlorophenyl)-n-phenyl-n-(chloroacetyl)-amine
HUP0001751A3 (en) A process for the preparation of 1,4,7,10-tetraazacyclododecane
HUP9800297A3 (en) Use of 3,4-diphenyl chromans for the manufacture of a vasodilatory pharmaceutical composition
EP0690053A3 (de) Verfahren zur Herstellung von 2,5-Dihydrofuran
AU2229597A (en) Model for the layer 1 iso-osi protocol intended to handle a set of common hardware resources
FR2687050B1 (fr) Perfectionnement sur des machines pour la preparation d'artichauts.
EP0799185A4 (en) DIMERES 1,3,3- (TRISUBSTITUES) CYCLOHEXANE AND RELATED COMPOUNDS
ZA953682B (en) Process for the manufacture of Form 1 ranitidine hydrochloride
DZ2386A1 (fr) Forme microparticulaire d'un dérivé de tétrahydropyridine
AU1972097A (en) Process for the preparation of form 1 ranitidine hydrochloride
EP0617130A3 (en) Method for solving racemic mixtures.
AU1325095A (en) Novel 3-(substituted methyl)-4-oxa-1-azabicyclo{3.2.0}heptan-7-one derivatives useful as antitumor agents
SG63714A1 (en) Process for the preparation of 5-(alkoxmethyl)-2, 3-pyridinedicarboximide compounds
EP0799181A4 (en) DIMERES 3.3- (DISUBSTITUTED) CYCLOHEXANE-1-CARBOXYLATE AND RELATED COMPOUNDS